NAGE: Niagen Bioscience Inc. Common Stock Stocks News on October 25, 2025

3 Growth Companies With Insider Ownership Up To 29%

NAGE

Simply Wall St.

12 days ago

3 Growth Companies With Insider Ownership Up To 29%

NAGE

Simply Wall St.

16 days ago

Owning 37% shares,institutional owners seem interested in Niagen Bioscience, Inc. (NASDAQ:NAGE),

NAGE

MT Newswires

19 days ago

Niagen Bioscience Raises Fiscal 2025 Net Sales Growth Outlook; Shares Up Pre-Bell

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

NAGE

Business Wire

19 days ago

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

NAGE

Business Wire

a month ago

AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

Three Growth Stocks With Strong Insider Commitment

NAGE

Simply Wall St.

a month ago

Three Growth Stocks With Strong Insider Commitment

NAGE

Simply Wall St.

4 months ago

Even though Niagen Bioscience (NASDAQ:NAGE) has lost US$55m market cap in last 7 days, shareholders are still up 623% over 3 years

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

NAGE

Business Wire

4 months ago

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

Niagen Bioscience to Participate in the BIO 2025 International Convention

NAGE

Business Wire

4 months ago

Niagen Bioscience to Participate in the BIO 2025 International Convention

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

NAGE

Business Wire

5 months ago

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference

NAGE

Business Wire

5 months ago

Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference

3 Growth Companies With High Insider Ownership And Up To 18% Revenue Growth

NAGE

Simply Wall St.

5 months ago

3 Growth Companies With High Insider Ownership And Up To 18% Revenue Growth

3 Stocks That May Be Trading Below Their Estimated Value

NAGE

Simply Wall St.

5 months ago

3 Stocks That May Be Trading Below Their Estimated Value

Exploring May 2025's Undervalued Small Caps With Insider Action

NAGE

Simply Wall St.

5 months ago

Exploring May 2025's Undervalued Small Caps With Insider Action

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations

NAGE

Simply Wall St.

5 months ago

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations

NAGE

GuruFocus.com

6 months ago

Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

NAGE

Business Wire

6 months ago

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

NAGE

Business Wire

6 months ago

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

Three High Growth Companies Insiders Are Eager To Hold

NAGE

Simply Wall St.

6 months ago

Three High Growth Companies Insiders Are Eager To Hold

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

NAGE

Business Wire

6 months ago

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

NAGE

Business Wire

6 months ago

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

NAGE

Simply Wall St.

6 months ago

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap up US$51m last week, benefiting both individual investors who own 36% as well as insiders

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

NAGE

Business Wire

7 months ago

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Growth Companies With High Insider Ownership For April 2025

NAGE

Simply Wall St.

7 months ago

Growth Companies With High Insider Ownership For April 2025

NAGE

Simply Wall St.

7 months ago

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)

Why ChromaDex Corp (CDXC) Is Surging In 2025?

NAGE

Insider Monkey

7 months ago

Latest Niagen Bioscience Inc. Common Stock (NAGE) News on October 25, 2025

3 Growth Companies With Insider Ownership Up To 29%

Owning 37% shares,institutional owners seem interested in Niagen Bioscience, Inc. (NASDAQ:NAGE),

Niagen Bioscience Raises Fiscal 2025 Net Sales Growth Outlook; Shares Up Pre-Bell

Niagen Bioscience Increases Full Year 2025 Net Sales Outlook to 25% to 30% Year-Over-Year Growth

AboutNADⓇ Debuts as the Leading Online Resource for Scientific Advancements in NAD+

Three Growth Stocks With Strong Insider Commitment

Even though Niagen Bioscience (NASDAQ:NAGE) has lost US$55m market cap in last 7 days, shareholders are still up 623% over 3 years

Niagen Bioscience to Participate at the Roth 15th Annual London Conference

Niagen Bioscience to Participate in the BIO 2025 International Convention

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder

Niagen Bioscience to Present at Oppenheimer’s 25th Annual Consumer Growth and E-Commerce Conference

3 Growth Companies With High Insider Ownership And Up To 18% Revenue Growth

3 Stocks That May Be Trading Below Their Estimated Value

Exploring May 2025's Undervalued Small Caps With Insider Action

Niagen Bioscience First Quarter 2025 Earnings: Beats Expectations

Niagen Bioscience Inc (NAGE) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Niagen Bioscience, Inc. Reports First Quarter 2025 Financial Results and Increases Outlook

Niagen Bioscience Announces Pharmaceutical-Grade Niagen® IV Is Now Available in Almost 600 Clinics Nationwide

Three High Growth Companies Insiders Are Eager To Hold

Niagen Bioscience Welcomes Dr. Pinchas Cohen to Scientific Advisory Board

Niagen Bioscience to Report First Quarter 2025 Financial Results on Wednesday, May 7, 2025

Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap up US$51m last week, benefiting both individual investors who own 36% as well as insiders

Niagen Bioscience Confirms Its Operations Remain Unaffected by New Tariffs

Growth Companies With High Insider Ownership For April 2025

A Look At The Fair Value Of Niagen Bioscience, Inc. (NASDAQ:NAGE)

Why ChromaDex Corp (CDXC) Is Surging In 2025?

Share on Social Networks: